# Expanded Access Neoantigen Vaccine in Solid Tumors

> **NCT03914872** · — · NO_LONGER_AVAILABLE · sponsor: **Washington University School of Medicine**

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **BIOLOGICAL:** Neoantigen DNA Vaccine
- **DEVICE:** Integrated electroporation device

## Key facts

- **NCT ID:** NCT03914872
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03914872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03914872, "Expanded Access Neoantigen Vaccine in Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03914872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*